Trade AEMD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Aethlon Medical, Inc. (AEMD) is trading at US$6.34, up 0.51% today as of Sep 21, 15:53 EDT. The company has a market capitalisation of US$1.94M. Over the past 52 weeks, AEMD has traded between US$1.41 and US$41.35. On Syfe you can trade AEMD with $0 commission and add it to your watchlist.
| Previous close | US$6.31 |
|---|---|
| Market cap | US$1.94M |
| 52-week range | US$1.41 – US$41.35 |
| Volume | 2.51M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aethlon Medical, Inc.
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.
Year: 1998
Aethlon Medical, Inc. (AEMD) stock is trading at US$6.34, +0.51% from the previous close of US$6.31.
The market cap for Aethlon Medical, Inc. (AEMD) stock is approximately US$1.94M.
The 52-week high for Aethlon Medical, Inc. (AEMD) stock is US$41.35.
The 52-week low for Aethlon Medical, Inc. (AEMD) stock is US$1.41.
Aethlon Medical, Inc. (AEMD) does not currently pay a dividend.
Stay on top of AEMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore